Related Experiment Videos
New therapeutics in spine metastases
1Neurosurgery Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. bilskym@mskcc.org
Expert Review of Neurotherapeutics
|November 9, 2005
Summary
Metastatic spinal tumors affect 5-10% of cancer patients. Advances in surgical, radiation, and chemotherapy techniques improve treatment outcomes, pain relief, and quality of life for these patients.
Area of Science:
- Oncology
- Neurosurgery
- Radiology
Background:
- Metastatic spinal tumors are a common complication of systemic cancer, affecting an estimated 5-10% of all cancer patients.
- Improving systemic cancer therapies lead to increased survival rates, consequently increasing the incidence of symptomatic spinal tumors requiring local treatment.
- The management of spinal tumors is complex, requiring multidisciplinary collaboration for optimal patient outcomes.
Purpose of the Study:
- To review the recent advancements in the multidisciplinary management of metastatic spinal tumors.
- To highlight the importance of continued innovation in spinal tumor treatment techniques.
- To emphasize the goals of spinal salvage in improving patient quality of life.
Main Methods:
- Review of recent literature and technological advancements in spinal tumor treatment over the last decade.
- Analysis of improvements in surgical techniques, instrumentation, radiographic imaging, radiation therapy, and chemotherapy.
- Discussion of the collaborative efforts among spine surgeons, radiologists, and oncologists.
Main Results:
- Significant evolution in treatment modalities for spinal tumors over the past 10 years.
- Improvements in surgical techniques, instrumentation, and adjuvant therapies have enhanced treatment efficacy.
- Radiographic imaging, radiation therapy, and chemotherapy have seen substantial developmental progress.
Conclusions:
- Continued development of spinal salvage techniques is crucial for improving patient care.
- Key goals include enhanced pain relief, restoration of mechanical stability, preservation of neurologic function, and sustained local tumor control.
- Technological advancements collectively contribute to better palliation and improved quality of life for patients with metastatic spinal disease.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.